Viewing Study NCT05412459

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:49 PM
Ignite Modification Date: 2026-06-01 @ 2:23 PM
Study NCT ID: NCT05412459
Status: COMPLETED
Last Update Posted: 2023-03-06
First Post: 2022-06-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: 99mTc-DARPinG3-based HER2 Expression Molecular Imaging in HER2-positive Breast Cancer During Chemo+Targeted Therapy
Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HER2-positive Breast Cancer View
None Female View
Keywords:

Keywords

Keyword Brief Keyword Text View
None 99mTc-DARPinG3 View
None Breast Cancer View
None HER2 expression View
None chemotherapy and targeted therapy View